BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22262777)

  • 21. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
    Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
    Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoinhibition and adapter function of Syk.
    Kulathu Y; Grothe G; Reth M
    Immunol Rev; 2009 Nov; 232(1):286-99. PubMed ID: 19909371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical role of c-Cbl-interacting protein of 85 kDa in the development and progression of head and neck squamous cell carcinomas through the ras-ERK pathway.
    Wakasaki T; Masuda M; Niiro H; Jabbarzadeh-Tabrizi S; Noda K; Taniyama T; Komune S; Akashi K
    Neoplasia; 2010 Oct; 12(10):789-96. PubMed ID: 20927317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
    Moyo TK; Wilson CS; Moore DJ; Eischen CM
    Oncogene; 2017 Aug; 36(32):4653-4661. PubMed ID: 28368423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
    Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Sibbet GJ; Sumpton D; Zanivan S; Hedley A; Clark W; Huang DT
    Oncogene; 2021 Mar; 40(12):2149-2164. PubMed ID: 33627783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.
    Take H; Watanabe S; Takeda K; Yu ZX; Iwata N; Kajigaya S
    Biochem Biophys Res Commun; 2000 Feb; 268(2):321-8. PubMed ID: 10679202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex.
    Kim J; Kang D; Sun BK; Kim JH; Song JJ
    Cell Signal; 2013 Jan; 25(1):372-9. PubMed ID: 23085457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.
    Juszczynski P; Chen L; O'Donnell E; Polo JM; Ranuncolo SM; Dalla-Favera R; Melnick A; Shipp MA
    Blood; 2009 Dec; 114(26):5315-21. PubMed ID: 19855081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The kinase Syk as an adaptor controlling sustained calcium signalling and B-cell development.
    Kulathu Y; Hobeika E; Turchinovich G; Reth M
    EMBO J; 2008 May; 27(9):1333-44. PubMed ID: 18369315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIN85 interacting proteins in B cells-specific role for SHIP-1.
    Büchse T; Horras N; Lenfert E; Krystal G; Körbel S; Schümann M; Krause E; Mikkat S; Tiedge M
    Mol Cell Proteomics; 2011 Oct; 10(10):M110.006239. PubMed ID: 21725061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CIN85 phosphorylation is essential for EGFR ubiquitination and sorting into multivesicular bodies.
    Schroeder B; Srivatsan S; Shaw A; Billadeau D; McNiven MA
    Mol Biol Cell; 2012 Sep; 23(18):3602-11. PubMed ID: 22833562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling.
    Sohn HW; Krueger PD; Davis RS; Pierce SK
    Blood; 2011 Dec; 118(24):6332-41. PubMed ID: 21908428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CIN85 modulates the down-regulation of Fc gammaRIIa expression and function by c-Cbl in a PKC-dependent manner in human neutrophils.
    Marois L; Vaillancourt M; Paré G; Gagné V; Fernandes MJ; Rollet-Labelle E; Naccache PH
    J Biol Chem; 2011 Apr; 286(17):15073-84. PubMed ID: 21372129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid desensitization of B-cell receptor by a dithiol-reactive protein tyrosine phosphatase inhibitor: uncoupling of membrane IgM from syk inhibits signals leading to Ca2+ mobilization.
    Rozsnyay Z; Sarmay G; Gergely J
    Immunol Lett; 1995 Jan; 44(2-3):149-56. PubMed ID: 7541023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex.
    Schmidt MHH; Hoeller D; Yu J; Furnari FB; Cavenee WK; Dikic I; Bögler O
    Mol Cell Biol; 2004 Oct; 24(20):8981-93. PubMed ID: 15456872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Src-like adaptor protein (SLAP) regulates B cell receptor levels in a c-Cbl-dependent manner.
    Dragone LL; Myers MD; White C; Gadwal S; Sosinowski T; Gu H; Weiss A
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18202-7. PubMed ID: 17110436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of LAT as a dual substrate for Lck and Syk in T lymphocytes.
    Jiang Y; Cheng H
    Leuk Res; 2007 Apr; 31(4):541-5. PubMed ID: 16938345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling.
    Rorsman C; Tsioumpekou M; Heldin CH; Lennartsson J
    J Biol Chem; 2016 May; 291(22):11608-18. PubMed ID: 27048651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia.
    Le Roy C; Deglesne PA; Chevallier N; Beitar T; Eclache V; Quettier M; Boubaya M; Letestu R; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N
    Blood; 2012 Jul; 120(2):356-65. PubMed ID: 22613791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
    Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
    EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.